Infinity Pharma to stop developing drug for rheumatoid arthritis

(Reuters) - Infinity Pharma said it would stop testing its lead drug as a treatment for rheumatoid arthritis after it failed the main goal in a mid-stage study.

Source: Reuters: Health - January 8, 2015 Category: Consumer Health News Tags: healthNews Source Type: news